Xconomy National

Archives

by in

Entry	Author	Date	Location
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting	Luke Timmerman	01/23/12	National
Merck Leads $10M Funding of HIV Diagnostics Firm Daktari	Arlene Weintraub	01/03/12	Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500	Luke Timmerman	12/12/11	National
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO	Luke Timmerman	12/06/11	Seattle
Sangamo Fails Diabetic Neuropathy Study, Falls Back on HIV, Other Programs	Luke Timmerman	10/03/11	San Francisco
Gates Foundation Adds Novartis Vet, Trevor Mundel, as New Global Health Leader	Luke Timmerman	09/13/11	Seattle
Theraclone Snaps Up $10.6M Financing	Luke Timmerman	09/08/11	Seattle
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science	Stewart Lyman	09/07/11	Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing	Luke Timmerman	09/06/11	Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue	Steve Worland	09/06/11	San Diego
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News	Luke Timmerman	08/25/11	Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News	Bruce V. Bigelow	08/18/11	San Diego
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine	Luke Timmerman	08/17/11	National
Gilead HIV Drug Gets FDA OK	Luke Timmerman	08/10/11	San Francisco
Merck and UCSF Team Up to Find New Weapons Against Resurgent HIV	Arlene Weintraub	07/20/11	New York
Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed	Luke Timmerman	07/20/11	Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News	Luke Timmerman	07/14/11	Seattle
Gilead Expands Low-Cost HIV Drug Program	Luke Timmerman	07/12/11	San Francisco
Hutch, Sangamo Win $20M HIV Grant	Luke Timmerman	07/11/11	Seattle
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig	Luke Timmerman	06/27/11	Seattle
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance	Arlene Weintraub	06/20/11	Boston
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company	Luke Timmerman	06/02/11	Seattle
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting	Luke Timmerman	05/23/11	San Francisco
The Resurgence of Gene and Cell Therapy	Barrie Carter	05/16/11	Seattle
VCs Turn Up The Heat on FDA to Get Faster, More Predictable	Luke Timmerman	04/25/11	National
Novartis, Trying Not to Burn the Hamburger, Increases its Bet on the Bay Area	Luke Timmerman	04/19/11	San Francisco
Gilead Drug Fails AIDS Prevention Trial	Luke Timmerman	04/18/11	San Francisco
Tobira Pegs Nodality Vet Andrew Hindman as CEO	Arlene Weintraub	04/04/11	New York
Gilead Inks $100M Deal With Yale	Luke Timmerman	03/31/11	San Francisco
Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV	Luke Timmerman	02/23/11	San Francisco
Page 1 of 5	next page »